Page last updated: 2024-10-31

molsidomine and Leukemia, Lymphocytic

molsidomine has been researched along with Leukemia, Lymphocytic in 1 studies

Molsidomine: A morpholinyl sydnone imine ethyl ester, having a nitrogen in place of the keto oxygen. It acts as NITRIC OXIDE DONORS and is a vasodilator that has been used in ANGINA PECTORIS.
molsidomine : A member of the class of oxadiazoles that is 1,2,3-oxadiazole substituted by morpholin-4-yl and (ethoxycarbonyl)azanidyl groups at positions 3 and 5, respectively. It is used as a vasodilator drug for the treatment of myocardial ischemic syndrome and congestive heart failure.

Research Excerpts

ExcerptRelevanceReference
"Pyrrolidine dithiocarbamate (PDTC) was cytotoxic on its own and inhibited NF-kappaB activity."1.31Killing of lymphoblastic leukemia cells by nitric oxide and taxol: involvement of NF-kappaB activity. ( Assreuy, J; Sampaio de Freitas, M; Santos-Silva, MC, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Santos-Silva, MC1
Sampaio de Freitas, M1
Assreuy, J1

Other Studies

1 other study available for molsidomine and Leukemia, Lymphocytic

ArticleYear
Killing of lymphoblastic leukemia cells by nitric oxide and taxol: involvement of NF-kappaB activity.
    Cancer letters, 2001, Nov-08, Volume: 173, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Survival; Cytoskeleton; Drug Synergism; Humans; Leuk

2001